-
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
25 Mar 2022 12:02 GMT
… )
On The Radar
PDUFA Dates
Zogenix, Inc.'s ZGNX supplemental … . PNT (before the market open)
IPOs
AN2 Therapeutics, Inc., ANTX, a … infectious diseases, priced its upsized initial public offering of 4.6 million shares …
-
Mid-Day Market Update: US Stocks Turn Negative; Zogenix Shares Spike Higher
19 Jan 2022 17:36 GMT
… .18 billion.
Equities Trading UP
Zogenix, Inc. (NASDAQ: ZGNX) shares shot … after the company priced its IPO at $10 per share.
Check …
-
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
04 Nov 2021 12:37 GMT
… Drug Approval, Kidney Conference, More IPOs In The Pipeline
Chimerix Sinks … . (NASDAQ: YMAB) (after the close)
Zogenix, Inc. (NASDAQ: ZGNX) (after the … )
IPOs
Hamburg, Germany-based Evotec SE (NASDAQ: EVO) priced its downsized initial public offering …
-
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct 2021 19:30 GMT
… (NASDAQ: YMAB) (after the close)
Zogenix, Inc. (NASDAQ: ZGNX) (after … (before the market open)
IPO Calendar
IPO Pricing
Hamburg, Germany-based … for a 22-million ADS initial public offering at a price of … symbol "NVCT."
IPO Quiet Period Expiry
Theseus …
-
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May 2021 11:52 GMT
… Therapeutics, Inc. (NASDAQ: YMTX)
Zogenix, Inc. (NASDAQ: ZGNX)
Stocks … (before the market open)
IPOs
Talaris Therapeutics, Inc., a … therapy company priced its initial public offering of 8.825 million … substance addiction, priced its IPO of 3 million shares …
-
The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs
16 Oct 2020 11:44 GMT
… (NASDAQ: QURE)
Stocks In Focus
Zogenix Presents Data Showing Durability of … L401 for infantile malignant osteopetrosis.
IPOs
Irvine, California-based Tarsus … ophthalmic conditions, priced its upsized initial public offering, or IPO, of 5.5 million …
-
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More
26 Jun 2020 12:22 GMT
… primarily by biotech firms. IPO research firm Renaissance Capital says … curable by surgery or radiation.
—Zogenix (NASDAQ: ZGNX) won FDA … dose.
THIS WEEK IN BIOTECH IPOS
—Cambridge, MA-based Relay … set a preliminary $100 million IPO goal.
—Irish biopharma Amryt …
-
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
21 Jun 2020 19:24 GMT
… flurry of activity on the IPO front.
The following are key … least two prior therapies. (Tuesday)
Zogenix, Inc.'s (NASDAQ: ZGNX …
-
Zeroing In On Zogenix
16 Mar 2020 19:29 GMT
… called Lennox-Gastaut syndrome. Zogenix stated the higher dose met … $23.50 per share. Zogenix is burning approximately $40 million … should support two players. Zogenix has a marketing agreement with … for the Biotech Forum, Busted IPO Forum, and Insiders Forum
…
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… )
Xeris Pharmaceuticals Inc (NASDAQ: XERS)
Zogenix, Inc. (NASDAQ: ZGNX)(announced extension … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …